NCT02878096View on ClinicalTrials.gov

Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Nocturia
Interventions
DRUG

[14C]-SK-1404

In Part 1, each subject will receive a single PO dose of SK-1404 followed by an IV microtracer dose of \[14C\]-SK-1404.

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

All Listed Sponsors
lead

Sanwa Kagaku Kenkyusho Co., Ltd.

INDUSTRY

NCT02878096 - Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study | Biotech Hunter | Biotech Hunter